Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20230207003
TCTR20230207003
Completed
Not Applicable

Propensity score-matched analysis of oncological and functional outcomes of submental island flap versus radial forearm free flap for oral cavity cancer reconstruction

/A0 sites133 target enrollmentFebruary 7, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsOral cavity cancer patients who underwent surgical resection and immediate reconstruction with a submental island flap or a radial forearm free flapOral cancer, Reconstruction, Pedicled flap, Free flap

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Oral cavity cancer patients who underwent surgical resection and immediate reconstruction with a submental island flap or a radial forearm free flap
Sponsor
/A
Enrollment
133
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 7, 2023
End Date
December 31, 2022
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
/A

Eligibility Criteria

Inclusion Criteria

  • •Patients aged more than 18 years with squamous cell carcinoma of the oral cavity who underwent surgical resection and immediate reconstruction with a submental island flap or a radial forearm free flap between October 2008 and December 2021\.

Exclusion Criteria

  • •Patients with recurrent oral cavity cancer or distant metastasis, those who required a segmental mandibulectomy, or patients who had undergone previous neck surgery or radiotherapy, or had a history of cancer elsewhere in the body.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Analysis of the risk profile of tumor patients
DRKS00033880niversitätsklinikum Augsburg, Medizinische Fakultät, Universität Augsburg2,000
Not yet recruiting
Not Applicable
Study of Patient/tumor/treatment related factors (Anemia, weight loss, muscle strength ect) on treatment toxicities and post treatment outcome
CTRI/2021/11/038031JIPMER
Active, not recruiting
Not Applicable
Assessment of tumor proportion for biomarker tests prior to the selection of first-line therapy in advanced non-squamous non-small cell lung cancer patients in the real world setting in Japan: a prospective, multicenter, observational studyon-Small Cell Lung Cancer
JPRN-jRCT1030210622Hiroshi Kitagawa240
Recruiting
Not Applicable
ongitudinal exploratory analysis of tumor-specific T-cell immunity and microbiome/calprotectin testing in patients with solid tumorsmalignancysolid tumor10027476
NL-OMON55886eids Universitair Medisch Centrum400
Suspended
Not Applicable
KUMAMON cancer registrymalignant disease
JPRN-UMIN000045346Kumamoto University35,000